Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GES
2976
PUT
DELISTED
Guess Inc
GES
| $986K | ﹤0.01% |
57,900
+29,300
| +102% | +$415K |
|
|
ENDP
2977
DELISTED
Endo International plc
ENDP
| $983K | ﹤0.01% |
114,783
-61,064
| -35% | -$588K |
|
2978
PUT
Equinix
EQIX
$104B
| $982K | ﹤0.01% |
2,200
-5,600
| -72% | -$2.51M |
|
|
SFLA
2979
DELISTED
iPath Long Extended S&P 500 TR Index ETN
SFLA
| $982K | ﹤0.01% |
5,159
| – | – |
|
2980
CALL
Assured Guaranty
AGO
$3.66B
| $978K | ﹤0.01% |
25,900
-60,400
| -70% | -$2.59M |
|
2981
Par Pacific Holdings
PARR
$3.51B
| $978K | ﹤0.01% |
47,058
+45,882
| +3,902% | +$832K |
|
|
OME
2982
DELISTED
Omega Protein
OME
| $978K | ﹤0.01% |
58,742
+54,439
| +1,265% | +$885K |
|
2983
Marvell Technology
MRVL
$189B
| $977K | ﹤0.01% |
54,661
-105,190
| -66% | -$1.75M |
|
2984
CALL
Knight Transportation
KNX
$11.5B
| $976K | ﹤0.01% |
+23,484
| New | +$890K |
|
|
SF
2985
Stifel
SF
$12.8B
| $971K | ﹤0.01% |
40,855
-2,214
| -5% | -$48K |
|
2986
Laureate Education
LAUR
$5.24B
| $970K | ﹤0.01% |
66,647
+57,719
| +646% | +$905K |
|
2987
Vanguard High Dividend Yield ETF
VYM
$82.5B
| $970K | ﹤0.01% |
11,965
+1,800
| +18% | +$143K |
|
|
KERX
2988
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $970K | ﹤0.01% |
136,615
+66,371
| +94% | +$477K |
|
2989
PUT
Ovintiv
OVV
$16B
| $969K | ﹤0.01% |
16,460
+5,280
| +47% | +$258K |
|
2990
CALL
Pultegroup
PHM
$25.3B
| $967K | ﹤0.01% |
35,400
+14,800
| +72% | +$375K |
|
|
CAVM
2991
DELISTED
Cavium, Inc.
CAVM
| $967K | ﹤0.01% |
14,659
-98,832
| -87% | -$6.25M |
|
2992
CALL
Johnson Controls International
JCI
$93.1B
| $966K | ﹤0.01% |
23,965
-84,330
| -78% | -$3.41M |
|
2993
Lantheus
LNTH
$6.61B
| $966K | ﹤0.01% |
54,196
-22,097
| -29% | -$388K |
|
2994
PUT
Ryder
R
$10.2B
| $964K | ﹤0.01% |
11,400
-700
| -6% | -$53K |
|
2995
UFP Industries
UFPI
$5.24B
| $964K | ﹤0.01% |
29,469
-14,274
| -33% | -$412K |
|
2996
PUT
iShares US Transportation ETF
IYT
$2.28B
| $963K | ﹤0.01% |
21,600
+4,800
| +29% | +$204K |
|
2997
PUT
America Movil
AMX
$72.1B
| $962K | ﹤0.01% |
54,200
-3,400
| -6% | -$61K |
|
2998
PUT
Brighthouse Financial
BHF
$3.55B
| $959K | ﹤0.01% |
+15,777
| New | +$900K |
|
2999
NNN REIT
NNN
$9.01B
| $958K | ﹤0.01% |
23,003
-102,271
| -82% | -$4.18M |
|
3000
ProShares UltraPro Short S&P 500
SPXU
$394M
| $956K | ﹤0.01% |
173
+92
| +114% | +$543K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.